Clinical Trial Update: Neurocognitive Assessment Platform 4 Alzheimer

View source ↗

Summary

This clinical trial update notes that a neurocognitive assessment platform for Alzheimer disease and mild cognitive impairment is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Snippet

Sponsor: IRCCS San Raffaele | Conditions: MCI, MCI Conversion to Dementia | Status: RECRUITING